CDK Global, Inc. provided earnings guidance for the year 2021. For the period, the company expects revenues to be $2,000 million - $2,050 million. GAAP Diluted earnings attributable to CDK per share to be $2.20 - $2.50. GAAP Net earnings attributable to CDK to be $270 million - $310 million. The company expects long-term revenue to grow at mid-single digit rates, with mid-single digit adjusted EBITDA growth in 2021 and 2022 before re-accelerating to a high-single digit or low-double digit growth target in 2023 and beyond.